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1. Introduction 
Since the introduction of the laparoscopic cholecystectomy, there has been explosive growth 
in the field of minimally invasive surgery. Commonly accepted laparoscopic procedures 
have now come to include bariatric and anti reflux procedures, distal pancreatectomy, 
splenectomy, hernia repair, and colon resection. The adoption of laparoscopy to the field of 
liver surgery; however, has been slower to take off. Initial concerns included inadequate 
exposure and ability to attain hemostasis, fear of gas embolism, and doubts over the 
oncologic adequacy of the less invasive procedure. The earliest reports of laparoscopic liver 
surgery were limited to wedge resections for staging or isolated metastases(Lefor, AT & 
Flowers, JL 1994). Laparoscopic liver resection finally started to gain serious widespread 
attention after publication of Cherqui’s initial thirty patient experience(Cherqui, D et al 
2000). Since that time, the field has seen explosive growth, with over 2,804 cases now 
described in the world literature(Nguyen, KT et al 2009). Despite its widespread acceptance, 
laparoscopic liver resection remains a daunting technical challenge suited to a relatively 
small number of centers that have taken the time and effort to develop concurrent expertise 
in both open hepatic surgery and laparoscopy. Once these hurdles are overcome; however, 
laparoscopic liver resection is a safe and highly effective procedure offering numerous 
patient benefits. In this chapter, we will describe the indications for laparoscopic liver 
resection, and outline the steps that should be taken by fledgling groups wishing to embark 
upon creating a laparoscopic liver resection program. 
2. Benign disease 
Benign liver tumors represent a diagnostic and therapeutic challenge. Traditionally, a highly 
conservative approach to benign hepatic tumors has been favored, owing to the historically 
high morbidity and mortality associated with open liver surgery. As operative and 
anesthetic techniques have improved, these hurdles have come down. Despite the increased 
safety of hepatic surgery, the indications for resection of benign hepatic tumors have 
changed little: symptomatic lesions, asymptomatic lesions at high risk of rupture or 
malignant degeneration, and inability to exclude malignancy nonoperatively. Because of 
concerns over oncologic adequacy, benign lesions represent the ideal starting point for a 
laparoscopic liver surgery program. Despite the attractiveness of minimally invasive 
surgery; however, surgeons should be cautioned that the ability to perform a laparoscopic 
resection should not change the indications for operation. 
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2.1.1 Epidemiology and presentation 
Hemangioma represents the most common benign liver tumor, accounting for 5-20% of 
liver lesions(Buell, JF et al  2010). These tumors typically occur in females in the third 
through fifth decades. Symptoms typically do not occur until the tumors grow relatively 
large (>5cm), and typically consist of abdominal pain resulting from stretching of 
Glisson’s capsule. There have been reports of spontaneous, traumatic, or iatrogenic 
rupture. A rare consequence of hemangioma is a consumptive coagulopathy resulting 
from sequestration of platelets and clotting factors within the tumor vasculature known as 
the Kasabach-Merritt syndrome. There is no potential for malignant degeneration with 
hepatic hemangioma.  
2.1.2 Diagnostic evaluation 
Hemangiomas demonstrate a typical pattern of enhancement on triple phase contrast 
enhanced CT. The lesion appears as a well circumscribed hypodense mass with peripheral 
enhancement in the arterial phase that will progress toward the center of the lesion. This 
pattern is typically known as centripetal enhancement. Sensitivity of triple phase CT has 
been reported from 75-85% with specificity of 75-100%(Trotter, JF & Everson, GT 2001). Even 
better results have been reported with the use of magnetic resonance imaging, with reported 
sensitivity and specificity of up to 95% and 100%, respectively (Semelka, RC et al  2001). 
Because of the highly vascular nature of these tumors, percutaneous biopsy of suspected 
hemangiomas is contraindicated.  
2.1.3 Indications for surgical resection 
As there is no malignant potential, symptomatic disease is the only generally accepted 
indication for surgical resection of hemangiomas. It should again be stressed that the 
availability of laparoscopy should not extend the indications for operation to asymptomatic 
patients. If pain is the indication for surgery, a thorough diagnostic workup is imperative to 
rule out other sources before attributing the symptoms to the hemangioma. The indication 
for surgery is more clear cut for large ruptured hemangioma, with patients often presenting 
in shock. Because of the dire consequences of rupture of large hemangioma, some surgeons 
would advocate the prophylactic resection of large lesions in patients with high risk 
occupations in areas remote from medical care. This opinion is controversial and should not 
be broadly applied.  
2.2 Focal nodular hyperplasia 
Focal nodular hyperplasia (FNH) is generally thought to arise as a hyperplastic proliferation 
of cells arising from an arterial malformation. This malformation may be congenital in 
nature such as telangiectasia or arteriovenous malformation, or may result from vascular 
injury (Paradis, V 2010; Wanless, IR et al  1985). Hyperplasia is thought to be a polyclonal 
process resulting from the hyperperfusion resulting from increased arterial flow (Gaffey, MJ 
et al  1996). The polyclonal nature of these lesions has significant impact on the radiographic 
evaluation of FNH, as it is the only common benign lesion that appears hot on Technetium 




Laparoscopic Liver Resection 
 
65 
2.2.1 Epidemiology, radiographic evaluation, and presentation 
FNH is typically an incidentally discovered lesion in women of late child bearing age, 
presenting most commonly from age 30 to 50. The female to male ratio has been reported at 
up to 8:1 (Mortele, KJ & Ros, PR 2002). Unlike hepatocellular adenoma, FNH is not 
influenced by oral contraceptive use. The radiographic appearance of focal nodular 
hyperplasia is typically diagnostic. On triple phase computed tomography, FNH will show 
transient enhancement on arterial phase. On delayed imaging, the characteristic central scar 
then becomes hyperenhancing. This central scar represents the vascular pedicle of the lesion 
and is pathognomonic. The most common diagnostic difficulty is distinguishing FNH from 
adenoma, which may best be achieved by contrast enhanced MRI. In this setting, sensitivity 
and specificity can reach 97% and 100%, respectively (Terkivatan, T et al  2006).  
 On histologic examination, FHN consists of benign hepatocytes arranged in a nodular 
pattern that are separated by fibrous septae originating in the central scar. Steatosis within 
the lesion may be evident (Paradis, V 2010). FNH is asymptomatic in upwards of 80% of 
cases (Buell, JF et al  2010). In very rare instances, these lesions may present with 
hemorrhage. There are no reported cases of malignant degeneration of FNH thus far. 
Because of this, there is no indication for resection of asymptomatic lesions, regardless of the 
size and number of lesions. Surgical resection is reserved for the rare cases in which the 
lesion is symptomatic or when the diagnosis is not secure. 
2.3 Hepatocellular adenoma 
Hepatic adenoma is a less common benign hepatic neoplasm, arising most commonly in 
women of child bearing age. There is a strong association between development of these 
lesions and oral contraceptive or androgenic steroid use. While the incidence is 0.1 per year 
per 100,000 patients who don’t use oral contraceptives, there is a marked increase to up to 4 
per 100,000 oral contraceptive users (Paradis, V 2010). The introduction of modern 
contraceptives with lower estrogen content has led to a decrease in incidence (Rooks, JB et al  
1979). Less common risk factors for the development of hepatocellular adenoma include 
glycogen storage disease type I and type III (Micchelli, ST et al  2008) 
2.3.1 Radiographic features 
Though typically presenting as solitary lesions, adenoma may also be present as multiple 
lesions. Hepatic adenomas can grow quite large, with tumors of up to 30cm reported in the 
literature. Ultrasonography typically lacks diagnostic utility for adenomas, which can range 
from hypo to hyper-echoic. Reported sensitivity of ultrasound is only around 30%(Di, SM et 
al  1996). The CT appearance is that of a discrete, hypodense lesion showing enhancement 
on arterial phase followed by washout on later images. T1 weighted MRI will show a hypo- 
to hyperintense lesion, while T2 images will show a lesion that is more isointense. 
Enhancement with gadolinium contrast is typically present on the arterial phase, with rapid 
washout in the venous phase. The fat content of these lesions creates a typical decrease in 
intensity on fat-suppressed MRI images (Motohara, T et al  2002). 
2.3.2 Clinical presentation 
Patients with hepatocellular adenoma are more likely to present with symptomatic disease 
than those with FNH. Epigastric or right upper quadrant pain is present in 25-50% of 
patients (Buell, JF et al  2010). Spontaneous hemorrhage is also relatively common with these 
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lesions, occurring in over 20% of patients. These complications are more likely to occur in 
men and with lesions greater than 5cm in diameter (Dokmak, S et al  2009). Perhaps the 
most feared complication of hepatocellular adenoma is malignant degeneration. The risk has 
been reported in the range of 8-10%(Dokmak, S et al  2009; Paradis, V 2010). Although 5cm 
is the generally accepted size at which malignant degeneration becomes a concern, cases 
have been reported in lesions as small as 4cm (Micchelli, ST et al  2008). There is also a 
greater risk of malignant degeneration in males and in patients with the metabolic 
syndrome. Malignancy within adenomas is typically discovered only after surgical 
resection. 
2.3.3 Management 
In the case of small adenomas in the setting of oral contraceptive use, a period of 
observation following the cessation of contraception is warranted. Surgical resection in this 
setting is then reserved for lesions which fail to regress or continue to grow after stopping 
the offending medication. As with other benign lesions, symptomatology that can clearly be 
attributed to the adenoma is also an indication for surgical resection. The presence of 
multiple adenomas, or adenomatosis, is an arbitrary distinction rather than a distinct 
pathologic subtype, thus indications for resection are the same as for solitary adenoma. 
Because of the well defined risk of malignant degeneration, there are also cases where 
resection of asymptomatic lesions is warranted. Generally accepted criteria include 
adenomas greater than 5cm in size, or any adenoma in a male, regardless of size (Dokmak, S 
et al  2009).  
2.4 Other benign lesions 
2.4.1 Angiomyolipoma 
Angiomyolipoma is a rare benign tumor of mesenchymal origin. They most commonly 
occur in women and are discovered as incidental findings. Histologically, angiomyolipoma 
is composed of fat cells, blood vessels, and smooth muscle. CT imaging will show early 
enhancement that remains throughout the more delayed phases. Positive staining with 
HMB-45, with negative staining for cytokeratins 18 and 19, help to secure the diagnosis 
(Ding, GH et al  2011; Sturtz, CL & Dabbs, DJ 1994). Malignant degeneration is very rare, as 
is rupture, with three cases reported in the world literature. Because of the rare nature of 
serious complications, an initially conservative management strategy of imaging follow up 
is recommended when the diagnosis is established. Recently proposed guidelines for 
surgical resection of angiomyolipoma are as follows: symptomatic disease, tumors greater 
than 6cm, tumors which grow on repeated imaging, tumors showing extrahepatic growth 
with risk of rupture, and inability to make a definitive diagnosis on imaging or biopsy 
(Ding, GH et al  2011). 
2.4.2 Nodular regenerative hyperplasia 
Nodular regenerative hyperplasia (NRH) is characterized by diffuse involvement of the 
liver by multiple regenerative nodules in the absence of significant fibrosis. The incidence of 
NRH in a large autopsy series has been reported at 2.6% (Wanless, IR 1990). The disease 
typically manifests in the setting of systemic disorders such as Felty’s syndrome or with the 
use of chemotherapeutic agents, of which azathioprine is the most common (Reshamwala, 
PA et al  2006). Complications are rare, as demonstrated by Wanless’ series in which only 1 
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of 64 patients suffered any form of complication from NRH. Specific treatment for NRH is 
not needed. Diagnosis is made on liver biopsy, with reticulin staining being particularly 
helpful in identifying the changes of hyperplasia. Therapy, instead, is directed at treating 
the underlying disorder or withdrawing the offending medication.  
2.4.3 Inflammatory pseudotumor 
Inflammatory pseudotumor of the liver is a benign reactive process, the pathogenesis of 
which is unclear. In the majority of cases in the literature, an infectious agent was found to 
be the causative agent. Symptoms, when present, are generally nonspecific including body 
pain, fever, weight loss, leukocytosis, and elevated transaminases. CT findings are generally 
not specific for the diagnosis, although spontaneous regression on followup imaging in 4-6 
weeks is commonly reported to occur (Seki, S et al  2004). Histological features include 
replacement of liver parenchyma by densely hylanized collagenous tissue and chronic 
inflammatory infiltrates. These features are missed on FNA, making core needle biopsy 
critical for accurate diagnosis (Tsou, YK et al  2007). In a review of eight cases, Tsou et al 
have suggested that inflammatory pseudotumor may best be thought of as a variant of a 
healing liver abscess. Thus, treatment consists of antibiotic therapy and nonsteroidal anti-
inflammatory drugs. With appropriate therapy, the lesion can be expected to spontaneously 
regress. Surgical therapy is thus reserved for cases with severe symptoms or when 
malignancy is unable to be reliably excluded. 
2.5 Technical considerations for resection 
The majority of benign liver lesions are asymptomatic, leaving surgical resection as an 
appropriate therapy only in cases of symptomatic disease that is clearly attributable to the 
lesion, or when the diagnosis remains in doubt following appropriate workup. The 
exception is for hepatocellular adenoma, where the risk of malignant degeneration 
mandates resection for lesions larger than 5cm or cases occurring in men.  
2.5.1 Patient positioning 
There are three commonly used patient positions employed in laparoscopic liver resection: 
supine, lateral decubitus, and the so-called French position in which the patient is supine 
with the legs in stirrups and the surgeon is positioned between the patient’s legs. The 
appropriate position is determined based on the location of the tumor, and the surgical 
technique to be employed. The French position has the advantage of allowing the surgeon to 
operate with both hands while assistants can retract from either side of the table. The supine 
position is best employed when approaching lesions on the left lobe or right anterior sector 
of the liver. The lateral decubitus position places the patient recumbent on their left side at 
an angle of sixty degrees. This position allows access to the posterior segments of the right 
liver, as the left side down positioning prevents the liver from falling dependently into the 
operative field. When a hand port is to be employed, it is generally placed in the right upper 
quadrant as dictated by the position of the tumor being resected. 
2.5.2 Anesthesia and intraoperative care 
The use of low CVP anesthesia has been a critical factor in the improved safety of modern 
hepatic surgery. This technique mandates the use of central venous catheters and arterial 
lines for patient monitoring. During the parenchymal transection phase, central venous 
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pressure is lowered to between 2 and 4 mmHg with the use of nitrates, nitrous oxide, and 
dieresis. Combined with the tamponade effect of pneumoperitoneum, this technique 
minimizes blood loss from venous parenchymal bleeding (Tranchart, H et al  2010). Concern 
has been raised over the possibility of carbon dioxide embolism during laparoscopic liver 
surgery; however, extensive use of CO2 as an intravenous contrast agent in interventional 
radiology procedures shows that these fears are probably overstated (Hawkins, IF & Caridi, 
JG 1998). Argon embolism, on the other hand, is a legitimate fear, and we advocate against 
the use of the argon beam coagulator on hepatic parenchymal veins. Furthermore, it is 
prudent to lower insufflations pressures during use of the argon beam. 
Minimization of blood product usage is another key component of intraoperative care. The 
use of intraoperative thromboelastography (TEG) allows for near real time assessment of the 
coagulation cascade with replacement of coagulation factors as appropriate. The cell saver is 
well accepted as a means of minimizing blood transfusion requirements during operation 
for benign indications. Cell saver use in the setting of malignancy is more controversial; 
however, the employment of adjunctive measures such as leukocyte depletion filters may 
minimize the burden of tumor cells in salvaged blood (Liang, TB et al 2008). 
2.5.3 Parenchymal transection techniques 
A number of parenchymal transection techniques have been described in the literature, with 
none of them showing clear superiority over the others. Which technique is ultimately 
chosen thus becomes dependent upon the individual surgeon’s comfort level with a given 
technique. Here we describe two of the more common strategies: electrosurgical dissection 
and stapler hepatectomy. 
Electrosurgical transection techniques rely upon the surgeon’s ability to operate two devices 
simultaneously. The surgeon should use a device such as the Harmonic Scalpel or Enseal 
(Ethicon Endosurgery, Cincinnatti, OH) in the dominant hand. This device is used to incise 
Glisson’s capsule and for the majority of parenchymal transection. The device should not be 
fully introduced into the parenchyma to prevent tearing of large vessels. When active 
bleeding is encountered, it is immediately controlled with bipolar cautery forceps which are 
held in the surgeon’s other hand. Larger vessels require the use of laparoscopic clips. The 
simultaneous use both devices is facilitated by sitting on a tall stool, which allows the 
surgeon to operate the foot pedals independently. 
Our group has favored the use of stapler hepatectomy. This technique provides the 
advantage of more rapid parenchymal transection, without the need for prior control of 
individual hepatic vessels. The first centimeter of parenchyma is relatively devoid of major 
vessels, and is incised with electrosurgical devices as described above. The dissection then 
proceeds using the thin blade of the stapler as a dissector. Care must be taken to avoid 
inadvertent manipulation of the stapler during firing, which can lead to tearing of major 
vessels and subsequent hemorrhage. The use of hand assistance is helpful in stabilizing the 
stapler to prevent such complications. We have preferred the use of a 25 mm vascular staple 
load for parenchymal transection. 
When intraoperative hemorrhage is encountered, the presence of a hand in the abdomen is 
highly beneficial in allowing digital control of bleeding vessels prior to attaining definitive 
hemostasis. The “quick stitch” as described by Koffron has proven highly useful in 
laparoscopic control of bleeding vessels. The quick stitch is a precut 10cm suture with two 
vascular clips placed on the tail of the suture. After the suture is placed and hemostasis is 
obtained, the closure is secured by additional clips place on the proximal end. Should 
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conversion be necessary during a pure laparoscopic procedure, it should initially be to a 
hand assist method rather than to full laparotomy. In all cases, conversion should not be 
viewed as a failure or complication, but rather as a measure of prudent judgment (Buell, JF 
et al  2009a). 
3. Laparoscopic liver surgery for malignancy 
After becoming comfortable with resection of benign lesions, the logical progression in the 
development of a laparoscopic liver program is the resection of malignant lesions. These 
lesions require an increased degree of skill on the part of the surgeons in order to attain 
adequate margins and maintain oncologic adequacy. The presence of cirrhosis in the setting 
of HCC or steatohepatitis following neoadjuvant chemotherapy for colorectal metastasis 
make proper patient selection and timing of operation critical. The consideration of 
adjunctive techniques such as transarterial chemoemboliztion for preoperative downstaging 
also becomes important. Here, we will discuss laparoscopic management of the two most 
common malignant hepatic tumors: colorectal metastases and hepatocellular carcinoma. 
3.1 Colorectal metastases 
Colorectal metastases are the most common malignant hepatic tumor. Results following 
open resection of these lesions have been excellent, with 5 year survival rates exceeding 50% 
in many centers (House, MG et al 2010). Such outcomes have set a high standard by which 
laparoscopic resection must be measured. The adoption of laparoscopy to this field has been 
hindered by concerns of tumor seeding at port sates and the possibility of missing 
extrahepatic lesions by inadequate inspection of the peritoneal cavity(Hsu, TC 2008; 
Johnstone, PA et al 1996). These hurdles have slowly been brought down, and laparoscopic 
resection is now a standard part of the therapeutic arsenal for hepatic malignancy. 
3.1.2 Patient selection 
Patient selection criteria for laparoscopic resection of colorectal metastases are similar to 
those applied for open resection. Initial evaluation requires precise definition of tumor 
anatomy and exclusion of extrahepatic disease. We favor triple phase CT as the initial 
radiographic evaluation. When combined with digital arterial reconstruction, evaluation of 
aberrant vascular anatomy, which can be present in nearly half of all patients, is afforded. 
Evaluation of baseline liver function is performed with evaluation of bilirubin, INR, and 
albumin. A thorough history and physical exam is necessary to assess general fitness for 
major abdominal surgery. Tumor resectability is defined by the SSAT as an expected 
negative margin resection with preservation of at least 2 contiguous hepatic segments with 
adequate inflow, outflow, and biliary drainage and a future liver remnant of more than 20% 
for normal parenchyma(Charnsangavej, C et al  2006). 
3.1.3 Neoadjuvant therapy 
The use of chemotherapy and chemoradiation for metastatic colon and rectal cancer has 
become a mainstay of therapy. Modern chemotherapeutic regimens generally consist of 5-
fluorouracil combined with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) have 
produced excellent response rates, and have been able to render 10-30% of previously 
unresectable disease amenable to surgical therapy. Agents such as cetuximab and 
bevacizumab have shown even better response rates. This efficacy is not without a price, 
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however. Bevacizumab has a black box warning for spontaneous intestinal perforation. 
Traditional chemotherapeutic combinations are hepatotoxic, leading to the phenomenon of 
chemotherapy associated steatohepatitis (CASH). These considerations are important, as 
patients are often referred for hepatic surgery after neoadjuvant therapy has been initiated. 
3.1.4 Operative considerations and oncologic adequacy 
The most critical factor to producing positive outcomes is the attainment of negative 
operative margins (R0 resection). Facility with laparoscopic intraoperative ultrasound is a 
must for surgeons approaching malignant liver lesions, allowing for precise definition of 
tumor anatomy and planning of resection planes. As long as negative microscopic margins 
are obtained, there does not appear to be a minimum necessary margin width (Pawlik, TM 
et al  2005). 
The approach to synchronous disease has received considerable attention, as it will be 
present in up to 25% of patients with colorectal liver metastases (Martin, RC et al  2009). 
There are three possible surgical strategies in this setting: the classic approach of colorectal 
resection followed by hepatectomy, a simultaneous resection of colorectal and hepatic 
disease, and a reverse strategy of metastasectomy followed by primary tumor resection. The 
drawback of the classic strategy is the delay in metastasectomy while patients receive 
adjuvant therapy. The combined strategy eliminates this delay, at the cost of greater surgical 
insult with possibly higher morbidity. The reverse strategy was described to eliminate the 
delay in metastasectomy while avoiding the surgical insult of the combined approach. With 
appropriate patient selection, groups from MD Anderson and the University of Louisville 
have demonstrated that the combined approach can be undertaken without increased 
morbidity and mortality. Brouquet’s analysis of all three strategies found similar morbidity, 
mortality, and survival across groups, showing that no approach is clearly superior for all 
patients (Brouquet, A et al  2010). 
With increasing worldwide experience of laparoscopic resection of colorectal metastases, the 
oncologic integrity of laparoscopy compared with open techniques has been shown to be 
comparable. Nguyen’s review of the world literature found only one case of port site 
recurrence, which occurred in a case of metastatic renal cell carcinoma that ruptured prior to 
resection (Nguyen, KT et al  2009). Castaing’s comparison of 60 patients undergoing 
laparoscopic resection and 60 patients undergoing open resection provided the first 
evidence of long term efficacy of laparoscopic resection for colorectal metastases. Five year 
survival in the laparoscopic group in this series was 62%, which was comparable to the 56% 
five year survival in the open group. There was no difference in width of resection margins 
between groups, while the laparoscopic group included a greater percentage of patients 
undergoing combined hepatic and colorectal resection (Castaing, D et al  2009). Such results 
confirm that laparoscopic resection is a safe and effective alternative to open surgery for 
hepatic colorectal metastases. 
3.2 Hepatocellular carcinoma 
Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third most 
common cause of cancer death worldwide (Parkin, DM et al  2005). In the United States, 
where chronic hepatitis C infection is the main risk factor, there has been an increase in the 
incidence of HCC over the past several decades (El-Serag, HB & Mason, AC 1999). Most 
patients present with relatively advanced disease, making curative treatment such as 
resection and liver transplantation applicable in only 30-40% of patients in Western centers 
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(Bruix, J & Llovet, JM 2002). One of the major limiting factors in preventing resectability is 
impaired hepatic function, with the vast majority of cases in Western patients developing in 
the background of cirrhosis. Thus, appropriate patient selection becomes paramount in 
achieving successful outcomes. Because of these limitations, the role of laparoscopic liver 
resection has remained more limited than for other disease states. 
3.2.1 Patient selection 
Much of the patient selection process for resection of HCC centers around assessment of the 
underlying liver parenchyma. The Child-Pugh classification system provides a rough 
framework from which to base the selection process. In generally, Child A patients are able 
to tolerate limited forms of resection, while Child B and C patients are typically referred for 
more palliative procedures such as systemic therapy or transarterial chemoembolization. In 
the West, assessment is directed at determining the presence of significant portal 
hypertension. Generally, patients with hepatic-venous pressure gradient of less than 10, 
esophageal varices of no greater than grade 1, and platelet counts of over 100,000 are 
considered acceptable risk. In addition, bilirubin levels must be normal. 
A common technique in Eastern centers is the assessment of indocyanine green clearance 
rate (ICG). This technique involves the injection of an organic dye which is then measured in 
the peripheral blood after a 15 minute interval. Clearance of the dye is used as a surrogate 
for hepatic metabolic function. ICG retention of no more than 10-20% is considered to be 
acceptable. Using this technique in 1056 consecutive patients with normal bilirubin and no 
ascites, Imamura has been able to achieve hepatic resection with zero operative mortality 
(Imamura, H et al  2003).  
Advances in imaging technology have lead to the increasing use of systemic liver volumetry 
as a preoperative risk assessment tool. A future liver remnant to standard liver volume ratio 
of greater than 20% is considered safe in patients with healthy liver parenchyma, while 
ratios of 30-40% are considered necessary for patients with compensated cirrhosis. An 
insufficient future liver remnant may be addressed with the use of adjunctive techniques 
such as portal vein embolization, which will be discussed in greater detail in the section on 
resection in cirrhotics. 
Tumor related factors that preclude surgical resection include extrahepatic disease and 
invasion of the main portal vein, vena cava, and common hepatic artery. Multinodular 
disease that can’t be resected with an adequate future liver remnant is also a relative 
contraindication to resection, although there is a role for resection of the dominant lesion 
with radiofrequency ablation of the remaining disease in highly selected cases. Although 
size alone is not a criteria for resectability, there is a practical limit to the size of lesion that 
can be safely approached laparoscopically. The recent international position statement for 
laparoscopic liver surgery recommends limitation of the laparoscopic approach to tumors 
<5cm in diameter for all but the most experienced of centers (Buell, JF et al  2009a). 
3.2.2 Technical considerations and oncologic adequacy 
Unlike the case of hepatic colorectal metastases, there does appear to be a benefit to wider 
surgical margins in patients with HCC. For patients with solitary HCC lacking vascular 
invasion, a margin of at least 2cm has proven beneficial in a randomized controlled trial 
setting. Furthermore, the tendency of HCC to spread via the portal venous system favors the 
use of planned anatomic resection in patients with adequate hepatic reserve. The inability to 
perform anatomic resection should not be considered a contraindication, however, as more 
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limited resection as been shown to be beneficial in the setting of cirrhosis (Rahbari, NN et al  
2011).  
Despite the limitations imposed by the greater difficulties in technical resection and patient 
selection, laparoscopic resection has proven to be a safe and effective alternative to open 
surgery in appropriately selected patients. Lai has demonstrated 5 year survival of 50%, 
with disease free survival of 36%, while Dagher has shown 5 year overall and disease free 
survival of 64.9% and 32.2%, respectively (Dagher, I et al  2010; Lai, EC et al  2009). Others 
have shown laparoscopic resection to be associated with lower morbidity and postoperative 
ascites compared to open resection (Belli, G et al  2009b). Although hepatocellular carcinoma 
in the setting of cirrhosis represents the most difficult of diseases to approach via 
laparoscopy, these results show that the technique is safe and effective when performed in 
centers that have acquired the appropriate experience. 
4. Laparoscopic resection in cirrhotics 
As noted above, the cirrhotic patient represents a unique challenge to the laparoscopic liver 
surgeon. The possibility of postoperative liver failure resulting from inadequate remnant 
liver function is a dreaded complication to be avoided at all costs. One technique that can 
potentially prevent this problem is the use of preoperative portal vein embolization (PVE). 
The effectiveness of PVE is based on the remarkable regenerative capacity of the liver. The 
technique involves occlusion of the tumor bearing segments of the liver, which induces 
hypertrophy in the remaining hepatic segments. Generally, reimaging 6 weeks after PVE is 
performed to assess the adequacy of hypertrophy to provide an adequate future liver 
remnant. Failure to achieve adequate hypertrophy indicates a severely diseased liver that is 
not amenable to resection. 
A meta-analysis of PVE has been found that the procedure is safe and able to induce 
adequate hypertrophy to reduce post resection liver failure in a considerable proportion of 
patients (Abulkhir, A et al  2008). Preoperative PVE is currently recommended in cirrhotic 
patients with predicted future liver remnant of less than 40%. For centers using ICG 
retention, values of 10-19% with a FLR of 40-60% also represents an indication for portal 
vein embolization (Rahbari, NN et al  2011).  
For cirrhotic patients able to undergo liver resection, laparoscopy provides a number of 
unique benefits. The smaller incisions cause less disruption of the abdominal wall collateral 
circulation. As complete evacuation of ascites is not necessary for a laparoscopic procedure, 
intraoperative fluid shifts are lessened. This contributes to the reduction in postoperative 
ascites seen with laparoscopy compared to open hepatectomy (Dagher, I et al  2009; Gigot, 
JF et al  2002). Another unique benefit is the reduced adhesion formation following 
laparoscopic surgery. For patients undergoing resection of HCC, salvage transplantation 
remains an important option for recurrences that are within the Milan criteria. Laurent 
found that liver transplants following laparoscopic compared to open resection were 
performed in less time, with less blood loss and transfusion requirement (Laurent, A et al  
2009). Similarly, Belli has found repeat hepatectomy following initial laparoscopic resection 
to be faster and safer, with less blood loss and risk of visceral injury (Belli, G et al  2009a).  
5. Development of a laparoscopic liver resection program 
The recent international consensus conference on laparoscopic liver surgery has developed 
guidelines for the establishment and credentialing of a laparoscopic liver surgery program 
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(Buell, JF et al  2009b). Prior to embarking upon beginning a program in laparoscopic liver 
surgery, it is necessary to acquire experience with both advanced laparoscopy and open 
hepatic surgery. These requirements have made the widespread adoption of laparoscopic 
liver surgery appropriately slow. As advanced laparoscopy becomes an increasingly 
important part of general surgery training programs, these prerequisites will become less of 
a hurdle, with the expected more rapid acceptance of laparoscopic liver surgery.  
After establishing the necessary expertise in laparoscopy and open hepatic surgery, the ideal 
starting point is small, benign lesions in the periphery of the liver. Extensive use of hand 
assistance is also critical in reducing the learning curve. Koffron has described the hybrid 
technique, in which mobilization of the liver is performed laparoscopically, and 
parenchymal transection is then performed in an open fashion through the hand port 
incision (Koffron, AJ et al  2007). He has termed this approach “laparoscopic liver surgery 
for everyone,” and we agree that this approach represents an ideal starting point for a 
laparoscopic liver program.  
Once comfortable with performing more limited resections, the next step in development is 
the performance of major, anatomic resections. In this setting, the left lateral segmentectomy 
is the ideal starting point. Although much attention is given to the parenchymal transection 
phase, it should be noted that the greatest risk for vascular injury and subsequent 
conversion to an open procedure is actually during the mobilization phase. The most 
commonly injured vessel in this setting is the phrenic vein, which must be carefully 
identified and avoided. Conversion, as we have emphasized previously, should not be 
viewed as a failure or complication. Instead, the decision to convert to an open or hand 
assisted procedure rather than continue with a potentially unsafe situation laparoscopically 
is a mark of good surgical judgment.  
Experience with resection of lesions located in the peripheral segments of the liver provides 
a foundation of skills, including mobilization, transection, hemostasis, and laparoscopic 
ultrasound. Once this fundamental skill set has been developed thoroughly, the surgeon is 
then able to proceed to more difficult lesions. At this point, malignant and/or large lesions 
located in the right and posterior segments of the liver can then be approached in the 
culmination of programmatic development. We have found that facility with minor 
resections can be achieved in 30 to 50 cases. More difficult resections such as formal 
lobectomy and right posterior resection require an additional 60 to 80 cases to master. Thus, 
the road to development of a laparoscopic liver resection program is long and often 
arduous, but is highly rewarding to both the surgeon and the patient when properly 
travelled.  
6. Conclusion 
Nearly 15 years after first being described, laparoscopic liver resection has been gradually 
gaining acceptance in a number of centers worldwide. As the necessary skills in advanced 
laparoscopy and hepatic surgery become more widespread, we anticipate that the further 
adoption of laparoscopic liver resection will increase more rapidly. The maturation of long 
term series have proven the oncologic adequacy of the laparoscopic approach in a variety of 
settings. With the development of a greater number of surgeons who are proficient in 
laparoscopic liver surgery, many more patients will benefit from decreased blood loss, less 
postoperative pain, and shorter lengths of stay. From being  a novel procedure practiced in 
only a handful of centers worldwide, laparoscopic liver resection is now established as  a 
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safe and effective technique in the therapeutic decision tree for patients with surgical disease 
of the liver. We believe that this acceptance will continue to grow to the point that the 
laparoscopic approach will, as has been seen with colon resection, eventually be adopted as 
the standard of care in appropriately selected patients. 
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